NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence.

BACKGROUND Mutations of NPHS2 are causative in familial autosomal-recessive (AR) and sporadic steroid-resistant nephrotic syndrome (SRNS). This study aimed to determine the spectrum of NPHS2 mutations and to establish genotype-phenotype correlations. METHODS NPHS2 mutation analysis was performed in 338 patients from 272 families with SRNS: 81 families with AR SRNS, 172 patients with sporadic SRNS, and 19 patients with diffuse mesangial sclerosis (DMS). RESULTS Twenty-six different pathogenic NPHS2 mutations were detected, including 13 novel mutations. The mutation detection rate was 43% for familial AR and 10.5% for sporadic SRNS, confirming genetic heterogeneity. No pathogenic NPHS2 mutations were found in DMS patients. Age at onset in patients with two pathogenic mutations was earlier, especially in cases with frameshift, truncating, and the R138Q missense mutations. Patients with only one NPHS2 mutation or variant had late-onset NS. Triallelic inheritance was observed in one patient with a homozygous R138Q mutation and a de novo NPHS1 mutation. Among 32 patients with two NPHS2 mutations who underwent kidney transplantation, only one developed late recurrence of focal segmental glomerulosclerosis (FSGS). Among 25 patients with sporadic SRNS and post-transplantation recurrence, we detected a heterozygous NPHS2 mutation in one case, and heterozygous variants/polymorphisms in 3 cases. CONCLUSION Patients with two pathogenic NPHS2 mutations present with early-onset SRNS and very low incidence of post-transplantation recurrence. Heterozygous NPHS2 variants may play a role in atypical cases with mild, late-onset course, and recurrence after transplantation.

[1]  O. Gribouval,et al.  Plasma Membrane Targeting of Podocin Through the Classical Exocytic Pathway: Effect of NPHS2 Mutations , 2004, Traffic.

[2]  M. Kretzler,et al.  Early Glomerular Filtration Defect and Severe Renal Disease in Podocin-Deficient Mice , 2004, Molecular and Cellular Biology.

[3]  T. Benzing,et al.  Molecular basis of the functional podocin-nephrin complex: mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains. , 2003, Human molecular genetics.

[4]  Bernhard Schermer,et al.  Nephrin and CD2AP Associate with Phosphoinositide 3-OH Kinase and Stimulate AKT-Dependent Signaling , 2003, Molecular and Cellular Biology.

[5]  F. Scolari,et al.  Podocin mutations in sporadic focal-segmental glomerulosclerosis occurring in adulthood. , 2003, Kidney international.

[6]  G. Rizzoni,et al.  Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  E. Unanue,et al.  CD2-Associated Protein Haploinsufficiency Is Linked to Glomerular Disease Susceptibility , 2003, Science.

[8]  G. Mazzucco,et al.  Broadening the spectrum of diseases related to podocin mutations. , 2003, Journal of the American Society of Nephrology : JASN.

[9]  Bethan E. Hoskins,et al.  Genetic interaction of BBS1 mutations with alleles at other BBS loci can result in non-Mendelian Bardet-Biedl syndrome. , 2003, American journal of human genetics.

[10]  T. B. Huber,et al.  NEPH1 defines a novel family of podocin‐interacting proteins , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  R. Kalluri,et al.  NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. , 2002, The Journal of clinical investigation.

[12]  G. Ghiggeri,et al.  Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome. , 2002, Journal of the American Society of Nephrology : JASN.

[13]  John Geibel,et al.  Calcium-pump inhibitors induce functional surface expression of ΔF508-CFTR protein in cystic fibrosis epithelial cells , 2002, Nature Medicine.

[14]  K. Tryggvason,et al.  Recurrence of nephrotic syndrome in kidney grafts of patients with congenital nephrotic syndrome of the Finnish type: role of nephrin. , 2002, Transplantation.

[15]  P. Scambler,et al.  Genotype/phenotype correlations of NPHS1 and NPHS2 mutations in nephrotic syndrome advocate a functional inter-relationship in glomerular filtration. , 2002, Human molecular genetics.

[16]  Y. Frishberg,et al.  Mutations in NPHS2 encoding podocin are a prevalent cause of steroid-resistant nephrotic syndrome among Israeli-Arab children. , 2002, Journal of the American Society of Nephrology : JASN.

[17]  F. Hildebrandt,et al.  Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. , 2002, Journal of the American Society of Nephrology : JASN.

[18]  N. Makridakis,et al.  Multiplex automated primer extension analysis: simultaneous genotyping of several polymorphisms. , 2001, BioTechniques.

[19]  G. Ghiggeri,et al.  Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. , 2001, Journal of the American Society of Nephrology : JASN.

[20]  M. Saleem,et al.  Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. , 2001, The Journal of clinical investigation.

[21]  T. Benzing,et al.  Interaction with Podocin Facilitates Nephrin Signaling* , 2001, The Journal of Biological Chemistry.

[22]  Bethan E. Hoskins,et al.  Triallelic Inheritance in Bardet-Biedl Syndrome, a Mendelian Recessive Disorder , 2001, Science.

[23]  Corinne Antignac,et al.  NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome , 2000, Nature Genetics.

[24]  J. Kaplan,et al.  Mutations in ACTN4, encoding α-actinin-4, cause familial focal segmental glomerulosclerosis , 2000, Nature Genetics.

[25]  M. Pericak-Vance,et al.  Linkage of a gene causing familial focal segmental glomerulosclerosis to chromosome 11 and further evidence of genetic heterogeneity. , 1999, Genomics.

[26]  E. Denamur,et al.  Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database. , 1998, American journal of human genetics.

[27]  L Peltonen,et al.  Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome. , 1998, Molecular cell.

[28]  Marc Fellous,et al.  Donor splice-site mutations in WT1 are responsible for Frasier syndrome , 1997, Nature Genetics.

[29]  S. Swan,et al.  Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. , 1996, The New England journal of medicine.

[30]  J. Beckmann,et al.  Mapping a gene (SRN1) to chromosome 1q25-q31 in idiopathic nephrotic syndrome confirms a distinct entity of autosomal recessive nephrosis. , 1995, Human molecular genetics.

[31]  D. Housman,et al.  Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome , 1991, Cell.

[32]  D. Housman,et al.  WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour , 1991, Nature.

[33]  O. Gribouval,et al.  Podocin localizes in the kidney to the slit diaphragm area. , 2002, The American journal of pathology.

[34]  J. Lamerdin,et al.  Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations. , 1999, American journal of human genetics.